Bookmarks

The Ninth International Conference on Clinical Ethics Consultation (ICCEC) 2013 will take place in Munich, Germany in March 2013. It is dedicated to the motto "Clinical ethics: bridging clinical medicine and ethics". The aim is to bring together ethicists, ethics consultants, and clinicians to reflect on their related practices, needs, concepts, and research results.

We encourage you and all colleagues who are interested in these discussions to submit their abstracts to the conference - deadline is October 15th.

If you have any questions or need for further information please visit our website http://www.iccec2013.de/call-for-abstracts/abstract-guidelines/abstract-guidelines.html or contact us directly via info@iccec2013.de.
Prof. Dr. W. Hiddemann
Conference Chairman

In this frequently updated blog Zachary M. Schrag critically disusses a number of issues relevant to the ethical review of humanities and social science research.

The tumult arising from revelations of serious safety risks associated with widely prescribed drugs, including rosiglitazone (Avandia, GlaxoSmithKline), rofecoxib (Vioxx, Merck), and celecoxib (Celebrex, Pfizer), has led to widespread recognition that improvement is needed in our national system of ensuring drug safety. Notwithstanding federal legislation in 2007 that strengthened the authority of the Food and Drug Administration (FDA) in the postmarketing period, critical weaknesses in the national system persist.

For the full report see: http://www.nejm.org/doi/full/10.1056/NEJMhle1207160